Clinical Trial Update: DHEA Treatment for Sjogren's Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dehydroepiandrosterone (DHEA) for Sjögren's syndrome has completed, examining symptoms related to tear and saliva production…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lacrimal Apparatus Disease
• Salivary Gland Disease
• Sjögren Syndrome
• Xerostomia

Drugs mentioned

• DHEA (dehydroepiandrosterone)

Snippet

Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) | Conditions: Lacrimal Apparatus Disease, Salivary Gland Disease | Phase 2 | Status: COMPLETED